-
-
As Climate Change Drives Fusion Energy Production, US Nuclear Poised To Capture Surging Tritium Monitoring Market
-
January is National Radon Action Month
-
US Nuclear January 2022 Shareholder Letter
Los Angeles, CA / January 12, 2022 / US Nuclear Corp. (OTCQB: UCLE)
Dear US Nuclear Corporation Shareholders,
Here we are. It is a new year and we wish all of you a safe, happy, and prosperous 2022. Unfortunately, the COVID pandemic is still affecting us all. Please stay well if you can. Our prayers go out to all those we have lost and their families.
On to business:
The COVID pandemic knocked down our revenue in 2020 due to shutdowns, restrictions, and precautions in response to the pandemic. The effects of the pandemic continued into 2021 due to supply chain and labor shortage problems. However, we are on our way back.
2020 Gross Revenue: $1,752,976
2021 Gross Revenue: $2,236,000*, up 27% from 2020
-
US NUCLEAR Closes Deadly Security Gaps by Monitoring Toxic Materials at Our Points of Entry
Los Angeles, CA. December 20, 2021 – US Nuclear Corp. (OTCQB: UCLE) uses the newest technologies to provide a wide variety of sensors to detect toxic or dangerous materials, for protecting all our points of entry including airports, seaports, sports stadiums, political conventions, and other large gatherings at risk from criminal or terrorist attacks. Included in US Nuclear’s lineup are the following systems for detecting radioactive materials, chemical and biological toxins, war gases, drugs, and explosives:
-
US Nuclear’s Drone System Pinpoints Methane Emissions and Leaks to Help Fight Climate Change
Los Angeles, CA. November 22, 2021 – At the recent COP26 climate change conference, the US and China unexpectedly unveiled a joint plan to accelerate their actions and work together to combat climate change. Their agreement features the reduction of methane emissions, and US Nuclear (OTCQB: UCLE) is ready to help support this goal through its Climate Drone with a laser-based methane detection system. On November 2, 2021, the US EPA proposed sweeping new standards to reduce manmade methane emissions from the oil and gas industry.
-
US Nuclear Corp. Announces Third Quarter 2021 Results
Los Angeles, CA. November 15, 2021 – US Nuclear Corp. (OTCQB: UCLE), a leading manufacturer of advanced radiation, chemical, and biological detection and UAV instrumentation, recently announced the financial results for the third quarter ended September 30, 2021.
- Sales for the three months ended September 30, 2021, were $683,771 compared to $484,318 for the same period in 2020, an increase of $199,453 or 41.2%
- Sales revenue continues to increase as the company recovers from COVID-19
- Selling, general, and administrative expense were $747,290 compared to $1,021,507 for the same period in 2020, the decrease of $274,217 or 26.8% was principally due to a decrease in stock-based compensation
- During the three months ended September 30, 2021, stock-based compensation was $72,250 compared to $542,560 during the same period in 2020
- Net loss of $444,383 compared to $850,386 for the same period in 2020
Robert Goldstein, CEO of US Nuclear Corp., commented:
“We had a very strong and productive third quarter, with sales revenue up 41.2% over the same period in 2020. While we are still affected by COVID-19 and supply chain issues, we continue to increase our revenue as we adapt and recover. September was a particularly busy month for us as we delivered on government contracts due by their fiscal year-end (September 30). We will keep up the momentum throughout the rest of the year as we work on fulfilling a large order backlog and several major contracts due by the calendar year-end. Recent news has focused on climate change, slowing global warming and tackling methane emissions, and we will address how US Nuclear is supporting climate change actions.”
Safe Harbor Act
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.
Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov, or the company’s website at http://www.usnuclearcorp.com
CONTACT:
US Nuclear Corp. (UCLE)
Robert I. Goldstein, President, CEO, and Chairman
Rachel Boulds, Chief Financial Officer
(818) 883 7043
Email: [email protected] -
US Nuclear Proudly Joins RAD-Responder Network, Securely Reporting Realtime Drone Data to U.S. DOE, NNSA, DTRA, EPA, FEMA, and Air Force
Los Angeles, CA. November 9, 2021 – US Nuclear (OTCQB: UCLE) recently partnered with the Ohio Department of Health (ODH) Radiation Emergency Preparedness Team to conduct a multi-agency flight training operation at the Calamityville Training Center in Ohio on June 22-23, 2021, showcasing USN’S unique ability to fully integrate its radiation payload data by connecting directly to the RadResponder Network. US Nuclear is currently the only drone vendor that has done this. The training exercise involved US Nuclear’s DroneRad system flying a perimeter around crashed vehicles to measure, map, and report the fallout from a radiological hazard.
Participants of the training operation included: US Air Force, US Nuclear Corp, Ohio Department of Transportation, Ohio Department of Health, and Wright State University.
The RadResponder Network is the national standard for the management of radiological data, created by a collaboration between FEMA, DOE, NNSA, EPA, and DTRA. It enables organizations to rapidly and securely record, share, and aggregate large quantities of data while managing equipment, personnel, interagency partnerships, and multijurisdictional event space.
With RadResponder, radiological hazards measured by US Nuclear’s drone systems are reported real-time to all relevant agencies (state, federal, local), allowing them to rapidly identify and react to threats.
Pictured above is a flight training operation performed with US Nuclear equipment at the Ohio Training Center. The scenario features a jet plane that has crashed with a radiological hazard. US Nuclear’s DroneRad flew an automatic search pattern to measure the fallout of the radiological hazard, with color-coded mapping software showing exactly where the hazard is.
US Nuclear has been enjoying increased interest and sales of their DroneRad system due to its unique detection and mapping of radiological, biological, and chemical hazards and ability to connect to RadResponder for radiation safety and defense. ODH recently purchased a DroneRad system from US Nuclear. US Nuclear provides drone systems that feature a truly outstanding 7-hour flight time and range of up to 10 miles depending on local regulations.
Benefits of US Nuclear’s DroneRad System:
- Fast and cost-effective coverage of large areas
- High sensitivity and identification of the type of radiation
- Worker protection
- Fast deployment prior to First Responder’s entering hazardous areas
- Ability to quickly and safely search out and detect a radioactive source in a vehicle or building
- Enhanced and cost-effective maintenance surveys for Nuclear Power Plants, Radiation Waste Repositories, Uranium Mines, Waste Disposal areas, etc.
- Wireless data download to ground station or First Responder cell phones
- Data archive and retrieval for historical documentation
Safe Harbor Act
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.
Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov, or the company’s website at http://www.usnuclearcorp.com
CONTACT:
US Nuclear Corp. (UCLE)
Robert I. Goldstein, President, CEO, and Chairman
Rachel Boulds, Chief Financial Officer
(818) 883 7043
Email: [email protected] -
US Nuclear’s Partner Grapheton Accelerates Product Development with New CEO
Los Angeles, CA. October 25, 2021 – US Nuclear’s (OTCQB: UCLE) partner Grapheton recently hired a new CEO, Terry Lingren, to accelerate product development by raising funds and allowing founder and CTO Sam Kassegne to focus on research and development.
Sam is the creative genius behind Grapheton’s glassy carbon supercapacitor technology that can benefit us all by speeding up EV chargers, augmenting or replacing EV onboard batteries, developing a new generation of computer chips with tiny supercapacitors, and advancing the treatment of neurological diseases and brain, spinal, and prosthetic cases. Mr. Lingren has significant experience raising capital, growing profitable businesses, and bringing high-tech products to market-clearing the way for rapid product development at Grapheton. Sam and Grapheton are also assisted by a scientific advisory board of 5 prestigious members specializing in fields such as bioengineering, neural technology, rehabilitative technology and medicine, microfabrication, and commercializing cutting-edge technology.
Grapheton is in several emerging industries (brain-computer interface, neural probes, and devices, supercapacitors for EV charging, and computer chip applications) which are clear opportunities for investors. Looking forward, Grapheton expects to have a number of income streams from these emerging industries where its patents and disruptive high-tech products and services are highly needed.
About Grapheton, Inc.
Founded in 2019, Grapheton is an early-stage company commercializing brain probes and power sources made from glassy carbon and graphene. These probes are completely biocompatible, corrosion-resistant, and non-toxic and can remain in the body for over ten years, unlike other probes which must be replaced every two years or less. Dr. Kassegne, a professor at San Diego State University who had served as Deputy Director of the National Science Foundation’s Center for Neurotechnology, has worked for over ten years with collaborators at the University of Washington and Massachusetts Institute of Technology (MIT). He and his team have three patents around the use of glassy carbon for brain probes and supercapacitors, as well as interconnecting glassy carbon with graphene.
Contact Grapheton:
Terry Lingren
(619) 990-5728
[email protected]
http://www.grapheton.comSafe Harbor Act
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.
Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov, or the company’s website at http://www.usnuclearcorp.com
CONTACT:
US Nuclear Corp. (UCLE)
Robert I. Goldstein, President, CEO, and Chairman
Rachel Boulds, Chief Financial Officer
(818) 883 7043
Email: [email protected] -
US Nuclear’s Partner, Grapheton, Appoints New Top Gun
Los Angeles, CA. October 18, 2021 – US Nuclear’s (OTCQB: UCLE) partner Grapheton, Inc., a pioneer in carbon-based biocompatible probes and power sources for brain-computer interfaces (BCI), today announced that Terry Lingren has been appointed Chief Executive Officer.
Mr. Lingren joins Grapheton with a proven track record of leadership in growing technology startups from concept through the market entry and high-volume manufacturing. He was the founding CEO of Resonant Inc. (NASDAQ: RESN) in 2012 and led it through its initial public offering in 2014 before retiring in 2017. Prior to Resonant, Mr. Lingren held executive and engineering positions at Qualcomm Inc. and Kyocera Wireless Corporation that led from the initial cellphone concept into dozens of products shipping millions of units per year.
“Terry’s experience in growing highly technical startups with novel products into revenue-producing companies is exactly the emphasis we need at this juncture in Grapheton’s young life,” said Sam Kassegne, Grapheton’s Co-Founder and Chairman of the Board. “His expertise and impressive track record in nurturing companies from early concepts into high-volume products will be invaluable as we move forward with commercialization of our BCI products.”
Mr. Lingren added, “I am excited to be joining Sam and his team on what I believe are disruptive products in the BCI market. This industry is poised for growth in helping people overcome disabilities and enhance their innate capabilities, and I hope to position Grapheton firmly in this growth.”
About Grapheton, Inc.
Founded in 2019, Grapheton is an early-stage company commercializing brain probes and power sources made from glassy carbon and graphene. These probes are completely biocompatible, corrosion-resistant, and non-toxic and can remain in the body for over ten years, unlike other probes which must be replaced every two years or less. Dr. Kassegne, a professor at San Diego State University who had served as Deputy Director of the National Science Foundation’s Center for Neurotechnology, has worked for over ten years with collaborators at the University of Washington and Massachusetts Institute of Technology (MIT). He and his team have three patents around the use of glassy carbon for brain probes and supercapacitors, as well as interconnecting glassy carbon with graphene.
Contact Grapheton:
Terry Lingren
(619) 990-5728
[email protected]
http://www.grapheton.comSafe Harbor Act
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.
Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov, or the company’s website at http://www.usnuclearcorp.com
CONTACT:
US Nuclear Corp. (UCLE)
Robert I. Goldstein, President, CEO, and Chairman
Rachel Boulds, Chief Financial Officer
(818) 883 7043
Email: [email protected]
US Nuclear Corp
Leader in Radiation Detection
